Meanwhile the stock is up by 5% today 
All GLS plants have regulated by USFDA, PMDA, COFEPRIS, Health Canada, MFDS (Korea), EDQM, other European regulatory agencies for various inspections and audits periodically and it doesn’t have any warning letters or import alerts from such regulatory authorities.
The closure notice by GPCB at Ankleshwar plant temporary affects the production, but it is negligible and will not make substantial impact beyond this quarter. If someone is invested with a short term horizon then that’s the different story. Nothing to bother for long term investors.
Regarding Dr Yasin Rawjee, company has a strong proven track record of strong EBITDA margins at 30% which reflects management capacity and quality. There is nothing wrong is being conservative while giving growth guidance because business scenario change with time or in given situation. i.e external factor can affect the demand just like red sea shipping crisis
Disc – invested
| Subscribe To Our Free Newsletter |
